Upgrade to SI Premium - Free Trial

Medtronic (MDT) Presents Positive Data from CoreValve U.S. Extreme Risk Study

October 30, 2013 10:04 AM
Following the first U.S. data presented on the Medtronic CoreValve System in patients treated via the transfemoral approach, Medtronic, Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles